-
Product Insights
Maida-Cortale VRG Wind Farm
Maida-Cortale VRG Wind Farm is an Onshore Wind project located in Calabria, Italy. The project is owned by F2i Fondi Italiani per le infrastrutture SGR SpA and was developed by Veronagest SpA. The project came online in 2010. Empower your strategies with our Maida-Cortale VRG Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VRG-50635 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VRG-50635 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MP-0310 in Anal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. MP-0310 in Anal Cancer Drug Details: MP-0310 is under development for the treatment of solid...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – RXDX-105 in Lung Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RXDX-105 in Lung Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RXDX-105 in Lung Adenocarcinoma Drug Details: RXDX-105 (CEP-32496) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PMX-205 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PMX-205 in Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PMX-205 in Alzheimer's Disease Drug Details:PMX-205 (TDI0116) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Livmoniplimab in Laryngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Livmoniplimab in Laryngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Livmoniplimab in Laryngeal Cancer Drug Details: Livmoniplimab (ABBV-151) is under development for...
-
Product Insights
Saigon VRG IHC – Le Minh Xuan III Industrial Park – Ho Chi Minh City
Equip yourself with the essential tools needed to make informed and profitable decisions with our Saigon VRG IHC - Le Minh Xuan III Industrial Park - Ho Chi Minh City report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – VRG-50635
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry VRG-50635 Drug Details VRG-50635 is under development for the treatment of amyotrophic lateral sclerosis....